Detailed information for compound 204747

Basic information

Technical information
  • TDR Targets ID: 204747
  • Name: N,N-dimethyl-8-[(4-methylphenyl)methyl]imidaz o[1,5-a][1,3,5]triazin-4-amine
  • MW: 267.329 | Formula: C15H17N5
  • H donors: 0 H acceptors: 3 LogP: 3.66 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: Cc1ccc(cc1)Cc1ncn2c1ncnc2N(C)C
  • InChi: 1S/C15H17N5/c1-11-4-6-12(7-5-11)8-13-14-16-9-17-15(19(2)3)20(14)10-18-13/h4-7,9-10H,8H2,1-3H3
  • InChiKey: IDZLBEKMQYLDLI-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • N,N-dimethyl-8-(p-tolylmethyl)imidazo[1,5-a][1,3,5]triazin-4-amine
  • N,N-dimethyl-8-(p-tolylmethyl)-4-imidazo[1,5-a][1,3,5]triazinamine
  • dimethyl-[8-(4-methylbenzyl)imidazo[1,5-a][1,3,5]triazin-4-yl]amine
  • N,N-dimethyl-8-[(4-methylphenyl)methyl]imidazo[5,1-f][1,3,5]triazin-4-amine
  • N,N-dimethyl-8-[(4-methylphenyl)methyl]-4-imidazo[5,1-f][1,3,5]triazinamine
  • dimethyl-[8-(4-methylbenzyl)imidazo[5,1-f][1,3,5]triazin-4-yl]amine

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Trichomonas vaginalis low molecular weight protein tyrosine phosphatase, putative 0.0048 0.4968 1
Leishmania major ubiquitin-conjugating enzyme e2, putative 0.0014 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0082 1 1
Trichomonas vaginalis low molecular weight protein tyrosine phosphatase, putative 0.0048 0.4968 1
Trichomonas vaginalis low molecular weight protein-tyrosine-phosphatase, putative 0.0048 0.4968 1
Entamoeba histolytica protein tyrosine phosphatase, putative 0.0048 0.4968 0.4968
Trypanosoma brucei ubiquitin-protein ligase, putative 0.0014 0 0.5
Loa Loa (eye worm) phosphotyrosine protein phosphatase 0.0048 0.4968 0.4968
Onchocerca volvulus 0.0048 0.4968 0.5
Trichomonas vaginalis low molecular weight protein tyrosine phosphatase, putative 0.0048 0.4968 1
Brugia malayi Low molecular weight phosphotyrosine protein phosphatase containing protein 0.0048 0.4968 1
Entamoeba histolytica protein tyrosine phosphatase, putative 0.0048 0.4968 0.4968
Mycobacterium ulcerans phosphotyrosine protein phosphatase PtpA 0.0048 0.4968 0.5
Toxoplasma gondii ubiquitin-conjugating enzyme subfamily protein 0.0014 0 0.5
Plasmodium falciparum ubiquitin-conjugating enzyme E2 N, putative 0.0014 0 0.5
Echinococcus multilocularis ubiquitin conjugating enzyme E2 N 0.0014 0 0.5
Echinococcus granulosus ubiquitin conjugating enzyme E2 N 0.0014 0 0.5
Trichomonas vaginalis low molecular weight protein-tyrosine-phosphatase, putative 0.0048 0.4968 1
Schistosoma mansoni ubiquitin conjugating enzyme 13 0.0014 0 0.5
Trichomonas vaginalis low molecular weight protein-tyrosine-phosphatase, putative 0.0048 0.4968 1
Giardia lamblia Low molecular weight protein-tyrosine-phosphatase 0.0048 0.4968 0.5
Plasmodium vivax ubiquitin-conjugating enzyme E2 N, putative 0.0014 0 0.5
Trypanosoma cruzi ubiquitin-conjugating enzyme E2, putative 0.0014 0 0.5
Trypanosoma cruzi ubiquitin-conjugating enzyme E2, putative 0.0014 0 0.5
Mycobacterium tuberculosis Phosphotyrosine protein phosphatase PtpA (protein-tyrosine-phosphatase) (PTPase) (LMW phosphatase) 0.0048 0.4968 0.5
Entamoeba histolytica Acid sphingomyelinase-like phosphodiesterase, putative 0.0082 1 1

Activities

Activity type Activity value Assay description Source Reference
CC50 (functional) = 411.9 uM Cytotoxic concentration required to inhibit CEM cell proliferation by 50%. ChEMBL. 7658442
CC50 (functional) = 411.9 uM Cytotoxic concentration required to inhibit CEM cell proliferation by 50%. ChEMBL. 7658442
IC50 (functional) > 374.5 uM Inhibitory concentration against parainfluenza-3 virus in vero cells ChEMBL. 7658442
IC50 (functional) > 749 uM Inhibitory concentration against influenza virus A in MDCK cells ChEMBL. 7658442
IC50 (functional) > 749 uM Inhibitory concentration against influenza virus B in MDCK cells ChEMBL. 7658442
IC50 (functional) > 749 uM Inhibitory concentration against respiratory syncytial virus in HeLa cells ChEMBL. 7658442
IC50 (functional) > 749 uM Inhibitory concentration against respiratory syncytial virus in HeLa cells ChEMBL. 7658442
MTC (ADMET) = 374.5 uM Minimum toxic concentration required to cause a microscopically detectable alteration of normal vero cell morphology ChEMBL. 7658442
MTC (ADMET) > 749 uM Minimum toxic concentration required to cause a microscopically detectable alteration of normal MDCK cell morphology ChEMBL. 7658442
MTC (ADMET) > 749 uM Minimum toxic concentration required to cause a microscopically detectable alteration of normal HeLa cell morphology ChEMBL. 7658442
MTC (ADMET) > 749 uM Minimum toxic concentration required to cause a microscopically detectable alteration of normal HeLa cell morphology ChEMBL. 7658442

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.